Data from: Identification of candidate risk factor genes for human idelalisib toxicity using a collaborative cross approach

Idelalisib is a phosphatidylinositol 3-kinase inhibitor highly selective for the delta isoform that has shown good efficacy in treating chronic lymphocytic leukemia and follicular lymphoma. In clinical trials, however, idelalisib was associated with rare, but potentially serious liver and lung toxic...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Mosedale, Merrie, Cai, Yanwei, Eaddy, J. Scott, Corty, Robert, Nautiyal, Manisha, Watkins, Paul B., Valdar, William
Format:	Dataset
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!